hansoh glp-1 Merck & Co. signs license agreement for Pharma receptor agonist GSK, Hansoh's targeted cancer drug

The National Institutes of Health (NIH) reports that acetaminophen overdose leads to over 500 deaths annually in the U.S

By integrating real-time hormonal lab results, genetic markers, and reported side effect data, an AI model could help predict a patient's sensitivity to the medications and potentially recommend a slower, more cautious titration schedule or a lower maintenance dose from the start, minimizing discontinuation rates and improving adherence

To help maintain or build lean muscle, look for ways to increase your physical activity levels in your daily routines

Quick Answer: GLP-1 receptor agonists are not FDA-approved for Crohn's disease and lack clinical trial evidence supporting their use in inflammatory bowel disease